P. Kwan

发表

Identification and Characterization of Rab25 as a Novel Tumor Suppressor Gene with Anti-Angiogenic and Anti-Invasive Activities in Esophageal Squamous Cell Carcinoma

S. Lok, K. Chan, X. Guan, 2012 .

Regulatory role of miR-142-3p on the functional hepatic cancer stem cell marker CD133

N. Wong, D. Xie, X. Guan, 2014, Oncotarget.

Tumor and Stem Cell Biology A CD 90 þ Tumor-Initiating Cell Population with an Aggressive Signature and Metastatic Capacity in Esophageal Cancer

S. Law, H. Lung, K. Chan, 2013 .

A CD90(+) tumor-initiating cell population with an aggressive signature and metastatic capacity in esophageal cancer.

S. Law, H. Lung, K. Chan, 2013, Cancer research.

miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.

I. Ng, K. Chan, N. Wong, 2010, Cell stem cell.

Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma.

S. Lok, K. Chan, X. Guan, 2012, Cancer research.

anti-invasive activities in esophageal squamous cell carcinoma Rab 25 is a tumor suppressor gene with anti-angiogenic and

S. Lok, K. Chan, X. Guan, 2012 .

Identification and Characterization of Rab 25 as a Novel Tumor Suppressor Gene with Anti-Angiogenic and Anti-Invasive Activities in Esophageal Squamous Cell Carcinoma

S. Lok, K. Chan, X. Guan, 2012 .

MicroRNA-616 induces androgen-independent growth of prostate cancer cells by suppressing expression of tissue factor pathway inhibitor TFPI-2.

K. Chan, X. Guan, M. Ling, 2011, Cancer research.

Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.

Na Zhang, Li Fu, Si Lok, 2012, Gastroenterology.

Daxx regulates mitotic progression and prostate cancer predisposition.

Y. Wong, M. Ling, C. Man, 2013, Carcinogenesis.

CD133+ liver tumor‐initiating cells promote tumor angiogenesis, growth, and self‐renewal through neurotensin/interleukin‐8/CXCL1 signaling

K. Chan, P. Lai, X. Guan, 2012, Hepatology.

CD133+ liver tumor‐initiating cells promote tumor angiogenesis, growth, and self‐renewal through neurotensin/interleukin‐8/CXCL1 signaling

K. Chan, P. Lai, X. Guan, 2012, Hepatology.